COCHW · Envoy Medical, Inc. · Analyst Estimates
$0.03
-0.01 (-21.91%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Since inception, the Company has historically incurred negative operating cash flows and losses from operations as the Company advances the clinical development of its products and the funding process of clinical FDA trials. These matters raise substantial doubt about the Company's ability to continue as a going concern and although management has developed plans intended to support ongoing operations, such plans do not alleviate the substantial doubt.”View the 10-Q filed Aug 10, 2026
Market Cap
$49.95M
Shares
77.19M
Volume · Oct 21
10K
Avg daily vol (3M)
32.54K
Analyst Estimates
Compare analyst forecasts for Envoy Medical, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-10-21 22:00 UTC · Publication dates shown per estimate · 8 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.31
|
-0.29
|
-0.27
|
3
|
-0.29
|
-0.30
|
-0.30
|
-0.29
|
0
|
0
|
0
|
1
|
|
Revenue
USD
Publication date not stated |
200,000.00
|
233,330.00
|
300,000.00
|
3
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.27
|
-0.24
|
-0.18
|
3
|
-0.24
|
-0.22
|
-0.22
|
-0.19
|
0
|
0
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
200,000.00
|
273,330.00
|
400,000.00
|
3
|
— | — | — | — | — | — | — | — |
Q ending 2026-09-30
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.07
|
-0.067
|
-0.06
|
3
|
-0.067
|
-0.07
|
-0.07
|
-0.07
|
1
|
1
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
55,000.00
|
85,000.00
|
100,000.00
|
3
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.09
|
-0.07
|
-0.06
|
3
|
-0.07
|
-0.075
|
-0.075
|
-0.06
|
1
|
1
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
55,000.00
|
85,000.00
|
100,000.00
|
3
|
— | — | — | — | — | — | — | — |